Rapidly Identifying HCPs Treating AML: The Lab Data Advantage
Acute myeloid leukemia (AML) is a rapidly progressing cancer of the blood and bone marrow,...
Unlocking Precision Targeting in Lysosomal Storage Disorders: How Prognos Health Empowers Commercial Teams
Lysosomal Storage Disorders (LSDs) present a unique challenge for pharmaceutical and biotech...
.png)
Brand Eligible Patient Alerts Supercharge Marketing & Sales Execution
Q: What are alerts? Why are pharma brand teams using brand eligible patient alerts as part of...